News

BioM's articles and press releases about the Bavarian biotechnology sector


2011 - almost done

The BioM-Team wishes Merry Christ­mas and a Happy New Year and the very best to our in­ter­na­tion­al part­ners, read­ers, vis­it­ors - and…

Personalized Medicine in Heart Failure: Corimmun Successfully Starts a Clinical Phase II Trial with COR-1

After very pos­it­ive data from the Phase-I-trial Martin­sried Cor­im­mun takes the next step in heart fail­ure treat­ment.

First Munich Biomarker Conference

Local her­oes and glob­al chal­lenges

Foundation stone is laid for the Biomedical Center in Großhadern-Martinsried

“The LMU HighTechCam­pus is already one of the world’s fore­most ad­dresses for life-sci­ence re­search. We are very pleased that the…

Munich and Europe: European EUROCALIN Consortium with a strong Munich hallmark

Pier­is com­pany in Fre­is­ing to co­ordin­ate fur­ther clin­ic­al de­vel­op­ment of a new class of com­pounds: an­tic­al­ins.

Biotechnologie am Campus Martinsried

Dezen­t­rales Pro­gramm der München­er Wis­senschaft­stage

Münchener Wissenschaftstage

m4 präsen­tiert sich im Haupt­ge­bäude der LMU

Biotechnica 2011

Han­nov­er

Munich and Japan

Osaka and Mu­nich join forces

BioM-Interview with Dr. Ulrich Dauer, CEO of 4SC AG

This year, the lis­ted 4SC AG from Martin­sried has had quite a lot of news to an­nounce, much of which has been pos­it­ive where pro­gress…

Newsletter

Subscribe

Archive


10.03.2025

Friedrich-Alexander-Universität Erlangen-Nürnberg

CAR-T-Zel­len: Lupus-Ther­apie bess­er ver­stehen

07.03.2025

vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

GKV-Fin­an­zier­ung nach­haltig auf­s­tel­len

07.03.2025

vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

Europäis­che Nutzen­be­w­er­tung: Poten­zi­al bleibt un­gen­utzt


Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager